FI52089C - Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia. - Google Patents
Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia.Info
- Publication number
- FI52089C FI52089C FI129371A FI129371A FI52089C FI 52089 C FI52089 C FI 52089C FI 129371 A FI129371 A FI 129371A FI 129371 A FI129371 A FI 129371A FI 52089 C FI52089 C FI 52089C
- Authority
- FI
- Finland
- Prior art keywords
- benzo
- preparation
- therapeutically active
- naphthyridine derivatives
- active cis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH708970A CH527822A (de) | 1970-05-13 | 1970-05-13 | Verfahren zur Herstellung neuer Benzonaphtyridin-Derivate |
| CH708670A CH527196A (de) | 1970-05-13 | 1970-05-13 | Verfahren zur Herstellung neuer Benzonaphthyridinderivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI52089B FI52089B (fi) | 1977-02-28 |
| FI52089C true FI52089C (fi) | 1977-06-10 |
Family
ID=25700728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI129371A FI52089C (fi) | 1970-05-13 | 1971-05-11 | Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia. |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5432799B1 (fi) |
| AT (1) | AT326674B (fi) |
| CA (1) | CA970377A (fi) |
| CS (2) | CS162753B2 (fi) |
| DE (1) | DE2123328A1 (fi) |
| DK (1) | DK134488B (fi) |
| ES (1) | ES391026A1 (fi) |
| FI (1) | FI52089C (fi) |
| FR (1) | FR2100649B1 (fi) |
| GB (1) | GB1361441A (fi) |
| NL (1) | NL7106502A (fi) |
| PL (1) | PL76913B1 (fi) |
| SE (1) | SE387640B (fi) |
| SU (1) | SU423296A3 (fi) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3899494A (en) * | 1970-05-13 | 1975-08-12 | Sandoz Ltd | Substituted 6-phenyl benzo-naphthyridines |
| NL7314396A (fi) * | 1972-10-26 | 1974-05-01 | ||
| BE880455A (fr) * | 1979-01-22 | 1980-06-06 | Sandoz Sa | Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine |
| PT988302E (pt) | 1997-06-03 | 2003-07-31 | Altana Pharma Ag | Benzonaftiridinas |
| HU229439B1 (hu) | 1999-08-21 | 2013-12-30 | Takeda Gmbh | Roflumilast és salmeterol szinergetikus kombinációja |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| EA200501548A1 (ru) | 2003-04-01 | 2006-02-24 | Апплайд Резеч Системз Арс Холдинг Н.В. | Ингибиторы фосфодиэстераз при бесплодии |
| BRPI0510951A (pt) * | 2004-05-12 | 2007-11-20 | Pfizer Prod Inc | derivados de piperidina como antagonistas de nk1 e nk3 |
| US20100120694A1 (en) | 2008-06-04 | 2010-05-13 | Synergy Pharmaceuticals, Inc. | Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| EP2527360B1 (en) | 2007-06-04 | 2015-10-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| JP6251038B2 (ja) | 2011-03-01 | 2017-12-20 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼｃアゴニストの調製方法 |
| JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
| JP2016514671A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼのアゴニストおよびその使用 |
| US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| ES2981866T3 (es) | 2013-06-05 | 2024-10-10 | Bausch Health Ireland Ltd | Agonistas ultrapuros de guanilato ciclasa C, método de elaboración y uso de los mismos |
| KR20160042039A (ko) | 2013-08-09 | 2016-04-18 | 알데릭스, 인코포레이티드 | 인산염 수송을 억제하기 위한 화합물 및 방법 |
| CN114340631A (zh) | 2019-05-21 | 2022-04-12 | 阿德利克斯股份有限公司 | 用于降低患者的血清磷酸盐的组合 |
-
1971
- 1971-05-10 GB GB1398471A patent/GB1361441A/en not_active Expired
- 1971-05-11 DE DE19712123328 patent/DE2123328A1/de not_active Ceased
- 1971-05-11 ES ES391026A patent/ES391026A1/es not_active Expired
- 1971-05-11 FI FI129371A patent/FI52089C/fi active
- 1971-05-11 CS CS341671A patent/CS162753B2/cs unknown
- 1971-05-11 PL PL14807271A patent/PL76913B1/pl unknown
- 1971-05-11 SU SU1656559A patent/SU423296A3/ru active
- 1971-05-11 CS CS920771A patent/CS167202B2/cs unknown
- 1971-05-11 DK DK225771A patent/DK134488B/da unknown
- 1971-05-12 SE SE613471A patent/SE387640B/xx unknown
- 1971-05-12 JP JP3189471A patent/JPS5432799B1/ja active Pending
- 1971-05-12 AT AT412471A patent/AT326674B/de not_active IP Right Cessation
- 1971-05-12 NL NL7106502A patent/NL7106502A/xx not_active Application Discontinuation
- 1971-05-12 CA CA112,767A patent/CA970377A/en not_active Expired
- 1971-05-12 FR FR7117124A patent/FR2100649B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES391026A1 (es) | 1974-04-01 |
| DK134488C (fi) | 1977-05-16 |
| SE387640B (sv) | 1976-09-13 |
| FR2100649B1 (fi) | 1974-08-30 |
| CS167202B2 (fi) | 1976-04-29 |
| GB1361441A (en) | 1974-07-24 |
| DK134488B (da) | 1976-11-15 |
| ATA412471A (de) | 1975-03-15 |
| FR2100649A1 (fi) | 1972-03-24 |
| CA970377A (en) | 1975-07-01 |
| JPS5432799B1 (fi) | 1979-10-16 |
| AT326674B (de) | 1975-12-29 |
| SU423296A3 (ru) | 1974-04-05 |
| PL76913B1 (en) | 1975-02-28 |
| CS162753B2 (fi) | 1975-07-15 |
| FI52089B (fi) | 1977-02-28 |
| NL7106502A (fi) | 1971-11-16 |
| DE2123328A1 (de) | 1971-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI52089C (fi) | Tapa valmistaa terapeuttisesti vaikuttavia cis-bentso/c//1,6/naftyridi ini-johdannaisia. | |
| NO140301C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(5,1-f)-as-triaziner | |
| SE400280B (sv) | 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner | |
| FI49300C (fi) | Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi. | |
| FI49515C (fi) | Menetelmä farmakologisesti vaikuttavien 11-asemaan substituoitujen 5,1 1-dihydro-6H-pyrido/2,3-b//1,4/bentsodiatsepiini-6-onien valmistamisek si. | |
| NO138565C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater | |
| FI49503C (fi) | Analogiamenetelmä 1,2,3,4-tetrahydro-4-fenyyli-isokinoliinijohdannaist en valmistamiseksi. | |
| FI48588C (fi) | Analogiamenetelmä terapeuttisesti vaikuttavien 3,4-dihydroisokinoliini johdannaisten valmistamiseksi. | |
| NO740327L (no) | Analogifremgangsmåte for fremstilling av farmakologisk aktive imidazopyridiner. | |
| NO741744L (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av naftyridin. | |
| FI49827C (fi) | Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi. | |
| FI49504C (fi) | Menetelmä farmakologisesti vaikuttavien bensosykloheptaisokinoliinijoh dannaisten valmistamiseksi. | |
| PH12247A (en) | Pharmaceutically active compounds | |
| NO136574C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrimidinderivater. | |
| NO740614L (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser. | |
| SE400768B (sv) | Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon | |
| NO741752L (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoderivater av pyrazolopyridin-ketoner. | |
| FI49718C (fi) | Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi. | |
| FI51349C (fi) | Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 6,7-bentsomor faanien valmistamiseksi. | |
| NO741044L (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive triaziner. | |
| FI49514C (fi) | Menetelmä farmaseuttisesti aktiivisten 11-asemaan substituoitujen 5,11 -dihydro-6H-pyrido(2,3-b)(1,4)bensodiatsepin-6-onien valmistamiseksi. | |
| FI50630C (fi) | Menetelmä farmakologisesti vaikuttavien 2,3,4,4a-tetrahydro-10H-1,2-ok satsino (3,2-b) (1,3) bentsoksatsiini-10-onien valmistamiseksi. | |
| FI50629C (fi) | Menetelmä uusien terapeuttisesti aktiivisten 2,3-dihydro-1H-tieno-bent sotiepino(4,5-c)pyrroli-yhdisteiden valmistamiseksi. | |
| FI47357C (fi) | Menetelmä terapeuttisesti vaikuttavien 4'-demetyyli-epipodofyllotoksii ni-beta-D-glukosidin johdannaisten valmistamiseksi. | |
| FI50875C (fi) | Menetelmä terapeuttisesti aktiivisten dihydro-2-aminoisokinoliinien va lmistamiseksi. |